Literature DB >> 11291247

Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy.

C Morishima1, D R Gretch.   

Abstract

This article reviewed various methods used for the diagnosis and monitoring of HCV infection and discusses potential clinical applications. Substantial improvements have recently been made in assay technology. Moreover, the role of molecular testing in the clinical setting of hepatitis C is becoming better defined. The major challenge facing clinical laboratories is the further refinement, implementation, and standardization of optimized molecular tests, so that reliable data may be made available to clinicians. In turn, clinicians must understand the limitations of each methodology, including the variability of testing that may occur among different laboratories. As more experience is gathered, molecular testing will probably provide important data regarding the most effective use of current and future therapies for individual patients to achieve maximum benefit in the management of hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11291247     DOI: 10.1016/s1089-3261(05)70235-x

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  7 in total

Review 1.  Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Rosa Zampino; Margherita Macera; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.

Authors:  Isabelle Desombere; Hans Van Vlierberghe; Sibyl Couvent; Filip Clinckspoor; Geert Leroux-Roels
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review.

Authors:  Rushna Firdaus; Kallol Saha; Aritra Biswas; Provash Chandra Sadhukhan
Journal:  World J Virol       Date:  2015-02-12

4.  Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.

Authors:  Sampa Pal; Margaret C Shuhart; Lisa Thomassen; Scott S Emerson; Tao Su; Nathan Feuerborn; John Kae; David R Gretch
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 5.  Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.

Authors:  Ekta Gupta; Meenu Bajpai; Aashish Choudhary
Journal:  Asian J Transfus Sci       Date:  2014-01

Review 6.  Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies.

Authors:  Shrikant Dashrath Warkad; Keum-Soo Song; Dilipkumar Pal; Satish Balasaheb Nimse
Journal:  Sensors (Basel)       Date:  2019-09-30       Impact factor: 3.576

Review 7.  Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries.

Authors:  Anoop Kumar; Manoj Kumar Rajput; Deepika Paliwal; Aakanksha Yadav; Reba Chhabra; Surinder Singh
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.